AtriCure Total Assets 2006-2019 | ATRC

AtriCure total assets from 2006 to 2019. Total assets can be defined as the sum of all assets on a company's balance sheet.
AtriCure Annual Total Assets
(Millions of US $)
2018 $357
2017 $268
2016 $276
2015 $273
2014 $158
2013 $112
2012 $32
2011 $34
2010 $34
2009 $35
2008 $43
2007 $46
2006 $39
2005 $50
AtriCure Quarterly Total Assets
(Millions of US $)
Q1 2019 $338
Q4 2018 $357
Q3 2018 $272
Q2 2018 $271
Q1 2018 $270
Q4 2017 $268
Q3 2017 $268
Q2 2017 $269
Q1 2017 $266
Q4 2016 $276
Q3 2016 $279
Q2 2016 $282
Q1 2016 $262
Q4 2015 $273
Q3 2015 $166
Q2 2015 $159
Q1 2015 $153
Q4 2014 $158
Q3 2014 $157
Q2 2014 $156
Q1 2014 $159
Q4 2013 $112
Q3 2013 $58
Q2 2013 $57
Q1 2013 $58
Q4 2012 $32
Q3 2012 $34
Q2 2012 $36
Q1 2012 $37
Q4 2011 $34
Q3 2011 $34
Q2 2011 $36
Q1 2011 $37
Q4 2010 $34
Q3 2010 $36
Q2 2010 $35
Q1 2010 $33
Q4 2009 $35
Q3 2009 $36
Q2 2009 $35
Q1 2009 $28
Q4 2008 $43
Q3 2008 $46
Q2 2008 $41
Q1 2008 $44
Q4 2007 $46
Q3 2007 $46
Q2 2007 $50
Q1 2007 $36
Q4 2006 $39
Q3 2006 $42
Q2 2006 $44
Q1 2006 $47
Q4 2005 $50
Q3 2005 $54
Q2 2005 $13
Q1 2005 $0
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $1.203B $0.202B
AtriCure, Inc. is a medical device company focused on developing, manufacturing and selling innovative surgical devices to create precise lesions, or scars, in soft tissues. Medical journals have described the adoption by leading cardiothoracic surgeons of the AtriCure, Inc. bipolar ablation system as a standard treatment alternative during open-heart surgical procedures to safely, rapidly and reliably create lesions in cardiac, or heart, tissue to block the abnormal electrical impulses that cause atrial fibrillation, a quivering of the upper chambers of the heart.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $154.348B 29.07
Medtronic (MDT) Ireland $135.189B 19.31
Stryker (SYK) United States $77.613B 27.70
Boston Scientific (BSX) United States $58.755B 28.17
Baxter (BAX) United States $42.395B 26.72
EssilorLuxottica Societe Anonyme (ESLOY) France $29.186B 0.00
Coloplast (CLPBY) Denmark $25.855B 41.28
Lonza Group Ag (LZAGY) Switzerland $25.565B 0.00
Zimmer Biomet Holdings (ZBH) United States $25.282B 16.24
Terumo (TRUMY) Japan $22.330B 25.68
Smith & Nephew SNATS (SNN) United Kingdom $18.881B 0.00
ResMed (RMD) United States $17.703B 33.83
Sunny Optical Technology (SNPTF) China $12.345B 0.00
Canopy Growth (CGC) Canada $12.272B 0.00
Bio-Rad Laboratories (BIO) United States $9.392B 49.79
William Demant Holdings (WILYY) Denmark $7.263B 0.00
Insulet (PODD) United States $7.231B 526.83
Hill-Rom Holdings (HRC) United States $7.018B 21.27
Perrigo (PRGO) Ireland $7.012B 11.85
Aurora Cannabis (ACB) Canada $6.936B 68.40
GN STORE NORD (GNNDY) Denmark $6.409B 32.73
Haemonetics (HAE) United States $6.251B 51.03
ICU Medical (ICUI) United States $5.188B 30.95
GW Pharmaceuticals (GWPH) United Kingdom $4.991B 0.00
Neogen (NEOG) United States $3.334B 54.21
NuVasive (NUVA) United States $3.016B 24.63
Hutchison China MediTech (HCM) China $2.777B 0.00
Agios Pharmaceuticals (AGIO) United States $2.746B 0.00
National Vision Holdings (EYE) United States $2.480B 52.83
Quidel (QDEL) United States $2.268B 23.54
Aphria (APHA) $1.604B 0.00
Cardiovascular Systems (CSII) United States $1.544B 886.40
Phibro Animal Health (PAHC) United States $1.216B 18.22
VAREX IMAGING (VREX) United States $1.174B 24.93
NanoString Technologies (NSTG) United States $1.114B 0.00
Lantheus Holdings (LNTH) United States $1.097B 29.13
PetIQ (PETQ) United States $1.015B 24.66
Quanterix (QTRX) United States $0.779B 0.00
Cerus (CERS) United States $0.761B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.750B 21.03
Omeros (OMER) United States $0.719B 0.00
MacroGenics (MGNX) United States $0.717B 0.00
TG Therapeutics (TGTX) United States $0.681B 0.00
LeMaitre Vascular (LMAT) United States $0.598B 28.97
OraSure Technologies (OSUR) United States $0.530B 24.40
Surmodics (SRDX) United States $0.527B 76.59
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.499B 0.00
Meridian Bioscience (VIVO) United States $0.492B 15.04
BioLife Solutions (BLFS) United States $0.330B 103.12
Utah Medical Products (UTMD) United States $0.321B 22.20
Vapotherm (VAPO) United States $0.320B 0.00
Zynex (ZYXI) United States $0.251B 25.77
Cytosorbents (CTSO) United States $0.242B 0.00
Bovie Medical (APYX) United States $0.214B 0.00
Chimerix (CMRX) United States $0.188B 0.00
Rockwell Medical (RMTI) United States $0.174B 0.00
United Health Products (UEEC) United States $0.170B 0.00
Owens & Minor (OMI) United States $0.166B 3.52
Fonar (FONR) United States $0.142B 7.49
Female Health (VERU) United States $0.134B 0.00
Chembio Diagnostics (CEMI) United States $0.103B 0.00
United-Guardian (UG) United States $0.092B 20.16
Surface Oncology (SURF) United States $0.076B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.067B 0.00
Trinity Biotech (TRIB) Ireland $0.053B 18.33